Long-Acting Delivery Systems in nAMD, DR, and DME

Patients with retinal diseases such as neovascular age-related macular degeneration (nAMD), diabetic retinopathy (DR), or diabetic macular edema (DME) face ongoing challenges in preserving vision, in part due to the need for frequent intravitreal injections. Treatment burden and fatigue may contribute to decreased adherence over time, resulting in visual outcomes in real-world practice that may differ from those achieved in pivotal clinical trials. US Food and Drug Administration-approved and emerging implantable and sustained drug delivery systems have been developed to reduce treatment burden by extending dosing intervals while maintaining visual and anatomical outcomes. In this CE podcast series, expert faculty discuss real-world-clinical scenarios designed to enhance clinical decision-making, procedural confidence, and practical incorporation of implantable drug delivery devices into everyday practice.